Texas in line for piece of drug maker's $19.5M settlement in deceptive trade practices case
Pharmaceutical giant Bristol-Myers Squibb Co. will pay a little more than $1 million to Texas as part of a $19.5 million, 42-state settlement over allegations of deceptive trade practices.
The allegations focused on the company's antipsychotic drug Ability and accusations the company marketed the drug to children and to patients diagnosed with dementia and Alzheimer's disease. But the drug did not have FDA approval to be marketed that way.
The drug, released in 2002, was originally approved to...